Clinical Trials Browser

Interventional × Carcinoma × Tablets × Clear all

NCT00941863 2016-03-22

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)

Phase 1 Completed

158 enrolled 17 charts

Carcinoma